(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid Basic information
- Product Name:
- (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid
- Synonyms:
-
- (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid
- (2S,4S)-1-((R)-2-((methoxycarbonyl) amino)-2-phenylacetyl)-4-(methoxy methyl)pyrrolidine-2-carboxylic acid
- (5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline
- (2S,5S)-1-((S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
- 3. (2S,5S)-1-((S)-2-((methoxycarbonyl)amino)-3- methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
- (2S,5S)-1-((S)-2-(methoxycarbonyl)-3-methylbutanoyl)
- (2S,5S)-1-(2-Methoxycarbonylamino-3-methyl-butyryl)-5-methyl-pyrrolidine-2-carboxylic acid
- N-[2-(S)-[(Methoxycarbonyl)amino]-3-methylbutyryl]-(5S)-5-Methyl-L-proline
- CAS:
- 1335316-40-9
- MF:
- C13H22N2O5
- MW:
- 286.32
- EINECS:
- 811-415-9
- Mol File:
- 1335316-40-9.mol
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid Chemical Properties
- Melting point:
- 134 - 136°C
- Boiling point:
- 489.9±40.0 °C(Predicted)
- Density
- 1.198±0.06 g/cm3(Predicted)
- refractive index
- 1.502
- Flash point:
- 250.1 ± 27.3 °C
- storage temp.
- -20°C, Inert atmosphere
- solubility
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- form
- Solid
- pka
- 3.61±0.40(Predicted)
- color
- Off-White to Pale Beige
- InChI
- InChI=1S/C13H22N2O5/c1-7(2)10(14-13(19)20-4)11(16)15-8(3)5-6-9(15)12(17)18/h7-10H,5-6H2,1-4H3,(H,14,19)(H,17,18)/t8-,9-,10-/m0/s1
- InChIKey
- PNAXKGVRCAXIJK-GUBZILKMSA-N
- SMILES
- C(O)(=O)[C@@H]1CC[C@H](C)N1C(=O)[C@H](C(C)C)NC(OC)=O
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid Usage And Synthesis
Uses
(5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline is an antiviral agent and Velpatasvir (V116000) intermediate. Velpatasvir is a NS5A inhibitor in patients with hepatitis C (HCV) infection.
Synthesis
To an ice-cold stirred solution of ethyl (2S,5S)-1 -[(2S)-2- (methoxycarbonylamino)-3-methyl-butanoyl]-5-methyl-pyrrolidine-2- carboxylate (5.6 g, 17.8 mmol) in ethanol (18 ml) is added a solution of lithium hydroxide monohydrate (17.8 mL of 1.7 M, 30.3 mmol). The reaction mixture is stirred for 5 hours at rt. The reaction mixture is concentrated, diluted with water, washed with ether. The aqueous solution is acidified with aq. 1 N HCl, extracted with CH2CI2. The combined extracts are washed with brine, dried (Na2S04), concentrated to afford (2S,5S)-1 -[(2S)-2-(methoxycarbonylamino)-3- methyl-butanoyl]-5-methyl-pyrrolidine-2-carboxylic acid (5g, 94%) as a white solid.
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acidSupplier
- Tel
- 14782051321
- market@lifebiology.cn
- Tel
- 021-34975603-808 18721111801
- sales@bocpharma.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 15527768850
- 1791901229@qq.com
- Tel
- 021-53292253
- biz@synches.com
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid(1335316-40-9)Related Product Information
- (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid
- Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S) -(2R,3R)-2,3-dihydroxybutanedioate (1:1)
- 9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one
- Aprepitant
- (2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid
- N-BOC-CIS-4-CYANO-L-PROLINE METHYL ESTER
- Velpatasvir intermediate
- Velpatasvir
- Velpatasvir intermediate
- Velpatasvir intermediate
- (R)-2-(methoxycarbonylamino)-2-phenylacetic acid
- Velpatasvir Co Povidone
- Velpatasvir intermediate
- BOC-L-PYROGLUTAMIC ACID BENZYL ESTER
- Velpatasvir-A12
- 3-(2-bromoacetyl)-10,11-dihydro-5H-Benzo[d]naphtho[2,3-b]pyran-8(9H)-one
- Velpatasvir intermediate -II-RS isomer
- (2S,4R)-4-(Methoxymethyl)-1,2-pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester